8 Min Read
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s;)
Nov 6 (Reuters) - U.S. stock index futures rose on Wednesday on the possibility the Federal Reserve may keep stimulus measures in place longer than anticipated ahead of data key later this week on the labor market and economic growth. S&P 500 futures were up 8.8 points, Dow Jones industrial average futures were up 67 points and Nasdaq 100 futures were up 12.25 points.
** TESLA MOTORS INC, Tuesday close $176.81, down 10.3 pct premarket
The company forecast a weaker-than-expected fourth-quarter profit and posted third-quarter Model S deliveries that disappointed some analysts as the electric car maker struggled to meet demand because of limited capacity.
** VIMPELCOM LTD, Tuesday close $14.33, down 11.3 pct premarket
The telecoms group, with assets in Russia, Italy and various emerging markets, said its third-quarter earnings fell 53 percent, hit by a tax expense as well as regulatory and competitive pressures.
** SUNTECH POWER HOLDINGS CO LTD, Tuesday close $1.50, down 13 pct premarket
The Chinese solar company said it filed an application for provisional liquidation in the Cayman Islands.
** AUXILIUM PHARMACEUTICALS INC, Tuesday close $17.29, up 5.5 pct premarket
The company reported a better-than-expected adjusted quarterly profit due to high sales of its urology drugs and raised the lower end of its full-year revenue forecast.
** TANGOE INC, Tuesday close $18.96, down 19.3 pct after market
The telecommunications software company lowered its full-year revenue forecast to $188.8 million-$189.3 million from $189 million-$191 million, citing a delay in implementation of some large customer contracts.
** BIOTELEMETRY INC, Tuesday close $9, up 12.2 percent after market
The medical technology company reported a surprise third-quarter profit due to strong volume growth in its services business that monitors heart rhythm disorders.
** RENEWABLE ENERGY GROUP INC, Tuesday close $11.77, up 10 pct after market
The biofuel maker reported a profit for the third quarter late on Tuesday, compared with a loss a year earlier, as it sold a record 77.6 million gallons of biodiesel. Revenue rose 42 percent to $458 million.
** MYRIAD GENETICS INC, Tuesday close $25.18, up 9 pct after market
The molecular diagnostics company raised its full-year forecast well above analysts' estimates on Tuesday after reporting a better-than-expected first-quarter profit. Sales of Myriad's cancer detection tests shot up. Myriad also said its board authorized a new $300 million stock buyback program that expands the company's total buyback program to $1 billion.
** SUNEDISON INC, Tuesday close $10.38, up 4 pct premarket
The company reported a quarterly loss, compared with a year-earlier profit, due to lower prices for its solar power plants and a drop in sales of solar panels.
** ABERCROMBIE & FITCH CO, Tuesday close $38.31, down 7.3 pct after market
** AEROPOSTALE INC, Tuesday close $9.2, down 4.8 pct after market
** AMERICAN EAGLE OUTFITTERS INC, Tuesday close $15.25, down 3.6 pct after market
Clothing retailer Abercrombie & Fitch reported another double-digit drop in quarterly same-store sales and warned of a tough holiday season, as the teen retailer struggles with the changing tastes of young shoppers.
Jefferies cut its price target on the stock to $45 from $50.
** ZELTIQ AESTHETICS INC, Tuesday close $15.34, down 6 pct after market
The medical device maker announced a public offering of 4.5 million shares, all of which were being offered by selling stockholders. Goldman Sachs & Co and J.P. Morgan Securities were acting as joint book-running managers for the offering.
** QEP RESOURCES INC, Tuesday close $33.28, down down 5.3 pct after market
The oil producer, which is under pressure from activist investor Jana Partners LLC, posted a lower-than-expected profit on Tuesday as a jump in commodity prices failed to offset a dip in production.
** GULFPORT ENERGY CORP, Tuesday close $60.53, up 5.2 pct after market
Analysts at Jefferies raised their price target on the oil and gas producer's stock to $82 from $78 on Tuesday, citing the company's better-than-expected quarterly profit due to lower lease expenses. Analysts said the company's product mix outlook, which included 50 percent to 70 percent of natural gas, is highly economic.
** SUCAMPO PHARMACEUTICALS INC, Tuesday close $6.48, up 5 pct after market
The drugmaker raised its full-year 2013 earnings forecast on Tuesday after higher product sales and lower expenses helped it beat average profit estimate for the third quarter.
** DAVITA HEALTHCARE PARTNERS INC, Tuesday close $56.53, down 4 pct after market
The largest U.S. operator of dialysis clinics reported third-quarter results that was in line with analysts' expectations on Tuesday. Operating expenses and charges rose substantially to about $2.62 billion in the quarter, Davita said in a statement. The company also narrowed its full-year operating income outlook.
** KINDRED HEALTHCARE INC, Tuesday close $14.91, down 4 pct after market
The hospital operator slashed its 2013 earnings forecast to a range below analysts' estimates on Tuesday, after reporting much lower-than-expected third-quarter results, citing sequestration and lower patient volumes that hurt revenue.
** JAZZ PHARMACEUTICALS PLC, $92.62, down 3 pct after market
The biopharmaceutical company posted better-than-expected quarterly results on strong sales of its drugs Xyrem and Erwinaze, but narrowed the range of its full-year revenue forecast. Jazz now expects to report revenue of $867-$877 million, compared with its prior view of $860-$880 million.
** VIVUS INC, Tuesday close $9.41, down 3 pct after market
The drugmaker reported a bigger-than-expected loss for the third quarter due to higher marketing expenses for its weight-loss pill Qsymia and charges related to a proxy contest with its biggest shareholder First Manhattan Co.
Chief Executive Seth Fischer said the company has reduced its workforce by 17 percent and has begun a process to seek European approval for the weight loss pill, which the region's regulators have earlier rejected on safety grounds.
** 21ST CENTURY FOX INC, Tuesday close $34.09, down 2 pct premarket
Rupert Murdoch's TV and film company reported quarterly earnings on Tuesday that missed Wall Street expectations, hurt by investments in new cable channels and a weaker performance from its movie releases.
** MAGNA INTERNATIONAL INC, Tuesday close $84.97
The Canadian auto parts manufacturer reported a nearly 13 percent rise in quarterly sales as its European business improved. Magna, which has been working to turn around inefficient operations in Europe amid the region's soft recovery, also raised the low end of it production sales outlook for 2013.
** COEUR MINING INC, Tuesday close $12.07, up 1 pct premarket
The largest U.S.-based silver miner is expected to report lower quarterly sales due to fall in production. The company, which is grappling with depressed metal prices like others precious-metal miners, may talk of plans to cut costs and of margin expectations.
** TIME WARNER INC, Tuesday close $68.23
The media company that owns HBO, Turner Entertainment and Warner Bros movie studio, is expected to show growth in its cable network unit when it reports quarterly results on Wednesday.
** RALPH LAUREN CORP, Tuesday close $171.19
The retailer is set to report quarterly earnings with Wall Street paying close attention to what the numbers say about orders from department stores ahead of the holiday season as well as trends in high-end apparel spending. (Compiled by Natalie Grover; Editing by Don Sebastion)